Skip to Main Content

Paper Details

Dysregulation of MS risk genes and pathways at distinct stages of disease.
Neurol Neuroimmunol Neuroinflamm
20
2017
CIS, MS, MS risk genes, MS risk variants, PBMCs, RESULTS Genes, dysregulated genes, gene, multiple sclerosis, peripheral blood mononuclear cells, relapsing-remitting MS
Author NameAffiliation
Mariaemma RodegherInstitute of Experimental Neurology (INSpe) (S.S., San Raffaele Scientific Institute, Milan University Vita-Salute San Raffaele (S.S., Institute for Cancer Research and Treatment (IRCC), University of Turin Medical School
Enzo MedicoInstitute of Experimental Neurology (INSpe) (S.S., San Raffaele Scientific Institute, Milan University Vita-Salute San Raffaele (S.S., Institute for Cancer Research and Treatment (IRCC), University of Turin Medical School
Vittorio MartinelliInstitute of Experimental Neurology (INSpe) (S.S., San Raffaele Scientific Institute, Milan University Vita-Salute San Raffaele (S.S., Institute for Cancer Research and Treatment (IRCC), University of Turin Medical School
Giancarlo ComiInstitute of Experimental Neurology (INSpe) (S.S., San Raffaele Scientific Institute, Milan University Vita-Salute San Raffaele (S.S., Institute for Cancer Research and Treatment (IRCC), University of Turin Medical School
  • 1 - 4

Datasets

Release 1.2